Norbert Marschner

Phase II study of nimotuzumab, a humanized monoclonal anti-epidermal growth factor receptor (EGFR) antibody, in patients with locally advanced or metastatic pancreatic cancer

F. Lordick, D. Strumberg, R. Hilger, 2012, Investigational New Drugs.